to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory...
Date First Received: August 7, 2007
Last Updated: August 7, 2007
Verified by: Baqiyatallah Medical Sciences University, August 2007
Clinical Trial Phase: Phase 3 | Start Date:
Overall Status: Completed
Brief Summary
Official Title: “Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study”
Condition Keyword(s):
Intervention(s):
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure
Study Type: Interventional
Study Design: Supportive Care, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Crossover Assignment
Intervention(s) in this Clinical Trial
- Drug: furosemide
Outcome Measures for this Clinical Trial
Primary Measures
- effect of furosemid inhalation on dyspnea
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients with a history of exposure to sulfur mustard with a complaint of dyspnea
Exclusion Criteria:
- A contraindication for furosemide use;
- An accompanying disease in which other drugs effective for dyspnea were used
Gender Eligibility for this Clinical Trial: Male
Minimum Age for this Clinical Trial: 32 Years
Maximum Age for this Clinical Trial: 83 Years
Clinical Trial Sponsor Information
Lead Sponsor: Baqiyatallah Medical Sciences University
Overall Clinical Trial Officials and Contacts
Mostafa Ghanei, MD Study Chair Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
Additional Information
Information obtained from ClinicalTrials.gov on November 20, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00512811
Study ID Number: 121a25
ClinicalTrials.gov Identifier: NCT00512811
Health Authority: Iran: Ethics Committee
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
